Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Mathematical modeling of the synergistic interplay of radiotherapy and immunotherapy in anti-cancer treatments

P. Castorina, F. Castiglione, G. Ferini, S. Forte, E. Martorana, D. Giuffrida

. 2024 ; 15 (-) : 1373738. [pub] 20240508

Language English Country Switzerland

Document type Journal Article

INTRODUCTION: While radiotherapy has long been recognized for its ability to directly ablate cancer cells through necrosis or apoptosis, radiotherapy-induced abscopal effect suggests that its impact extends beyond local tumor destruction thanks to immune response. Cellular proliferation and necrosis have been extensively studied using mathematical models that simulate tumor growth, such as Gompertz law, and the radiation effects, such as the linear-quadratic model. However, the effectiveness of radiotherapy-induced immune responses may vary among patients due to individual differences in radiation sensitivity and other factors. METHODS: We present a novel macroscopic approach designed to quantitatively analyze the intricate dynamics governing the interactions among the immune system, radiotherapy, and tumor progression. Building upon previous research demonstrating the synergistic effects of radiotherapy and immunotherapy in cancer treatment, we provide a comprehensive mathematical framework for understanding the underlying mechanisms driving these interactions. RESULTS: Our method leverages macroscopic observations and mathematical modeling to capture the overarching dynamics of this interplay, offering valuable insights for optimizing cancer treatment strategies. One shows that Gompertz law can describe therapy effects with two effective parameters. This result permits quantitative data analyses, which give useful indications for the disease progression and clinical decisions. DISCUSSION: Through validation against diverse data sets from the literature, we demonstrate the reliability and versatility of our approach in predicting the time evolution of the disease and assessing the potential efficacy of radiotherapy-immunotherapy combinations. This further supports the promising potential of the abscopal effect, suggesting that in select cases, depending on tumor size, it may confer full efficacy to radiotherapy.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013973
003      
CZ-PrNML
005      
20240905134153.0
007      
ta
008      
240725e20240508sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fimmu.2024.1373738 $2 doi
035    __
$a (PubMed)38779678
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Castorina, Paolo $u Genomics and molecular oncology unit, Istituto Oncologico del Mediterraneo, Viagrande, Italy $u Istituto Nazionale di Fisica Nucleare, Sezione di Catania, Catania, Italy $u Faculty of Mathematics and Physics, Charles University, Prague, Czechia
245    10
$a Mathematical modeling of the synergistic interplay of radiotherapy and immunotherapy in anti-cancer treatments / $c P. Castorina, F. Castiglione, G. Ferini, S. Forte, E. Martorana, D. Giuffrida
520    9_
$a INTRODUCTION: While radiotherapy has long been recognized for its ability to directly ablate cancer cells through necrosis or apoptosis, radiotherapy-induced abscopal effect suggests that its impact extends beyond local tumor destruction thanks to immune response. Cellular proliferation and necrosis have been extensively studied using mathematical models that simulate tumor growth, such as Gompertz law, and the radiation effects, such as the linear-quadratic model. However, the effectiveness of radiotherapy-induced immune responses may vary among patients due to individual differences in radiation sensitivity and other factors. METHODS: We present a novel macroscopic approach designed to quantitatively analyze the intricate dynamics governing the interactions among the immune system, radiotherapy, and tumor progression. Building upon previous research demonstrating the synergistic effects of radiotherapy and immunotherapy in cancer treatment, we provide a comprehensive mathematical framework for understanding the underlying mechanisms driving these interactions. RESULTS: Our method leverages macroscopic observations and mathematical modeling to capture the overarching dynamics of this interplay, offering valuable insights for optimizing cancer treatment strategies. One shows that Gompertz law can describe therapy effects with two effective parameters. This result permits quantitative data analyses, which give useful indications for the disease progression and clinical decisions. DISCUSSION: Through validation against diverse data sets from the literature, we demonstrate the reliability and versatility of our approach in predicting the time evolution of the disease and assessing the potential efficacy of radiotherapy-immunotherapy combinations. This further supports the promising potential of the abscopal effect, suggesting that in select cases, depending on tumor size, it may confer full efficacy to radiotherapy.
650    _2
$a lidé $7 D006801
650    12
$a nádory $x terapie $x imunologie $x radioterapie $7 D009369
650    12
$a imunoterapie $x metody $7 D007167
650    _2
$a kombinovaná terapie $7 D003131
650    _2
$a teoretické modely $7 D008962
650    _2
$a radioterapie $x metody $7 D011878
655    _2
$a časopisecké články $7 D016428
700    1_
$a Castiglione, Filippo $u Biotech Research Center, Technology Innovation Institute, Abu Dhabi, United Arab Emirates $u Institute for Applied Computing, National Research Council of Italy, Rome, Italy
700    1_
$a Ferini, Gianluca $u Radiotherapy Unit, REM Radioterapia, Viagrande, Italy $u School of Medicine, University Kore of Enna, Enna, Italy
700    1_
$a Forte, Stefano $u Genomics and molecular oncology unit, Istituto Oncologico del Mediterraneo, Viagrande, Italy
700    1_
$a Martorana, Emanuele $u Genomics and molecular oncology unit, Istituto Oncologico del Mediterraneo, Viagrande, Italy
700    1_
$a Giuffrida, Dario $u Genomics and molecular oncology unit, Istituto Oncologico del Mediterraneo, Viagrande, Italy
773    0_
$w MED00181405 $t Frontiers in immunology $x 1664-3224 $g Roč. 15 (20240508), s. 1373738
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38779678 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905134147 $b ABA008
999    __
$a ok $b bmc $g 2143649 $s 1225839
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 15 $c - $d 1373738 $e 20240508 $i 1664-3224 $m Frontiers in immunology $n Front Immunol $x MED00181405
LZP    __
$a Pubmed-20240725

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...